104 related articles for article (PubMed ID: 8723158)
1. No effects on heart-rate variability and cardiovascular reflex tests after botulinum toxin treatment of cervical dystonia.
Nebe A; Schelosky L; Wissel J; Ebersbach G; Scholz U; Poewe W
Mov Disord; 1996 May; 11(3):337-9. PubMed ID: 8723158
[No Abstract] [Full Text] [Related]
2. Botulinum toxin in cervical dystonia.
Tsui JK; Calne DB
Adv Neurol; 1988; 49():473-8. PubMed ID: 3344637
[No Abstract] [Full Text] [Related]
3. Treatment with botulinum toxin in a patient with myasthenia gravis and cervical dystonia.
Fasano A; Bentivoglio AR; Ialongo T; Soleti F; Evoli A
Neurology; 2005 Jun; 64(12):2155-6. PubMed ID: 15985599
[No Abstract] [Full Text] [Related]
4. Extensor truncal dystonia: successful treatment with botulinum toxin injections.
Comella CL; Shannon KM; Jaglin J
Mov Disord; 1998 May; 13(3):552-5. PubMed ID: 9613753
[TBL] [Abstract][Full Text] [Related]
5. Idiosyncratic adverse reactions to intramuscular botulinum toxin type A injection.
LeWitt PA; Trosch RM
Mov Disord; 1997 Nov; 12(6):1064-7. PubMed ID: 9399239
[TBL] [Abstract][Full Text] [Related]
6. Management of dystonia of the lateral pterygoid muscle with botulinum toxin A.
Mendes RA; Upton LG
Br J Oral Maxillofac Surg; 2009 Sep; 47(6):481-3. PubMed ID: 18829144
[TBL] [Abstract][Full Text] [Related]
7. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
[TBL] [Abstract][Full Text] [Related]
8. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
Bihari K
Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
[TBL] [Abstract][Full Text] [Related]
9. [Aspects of the complexity of cervical dystonia].
Hefter H
Nervenarzt; 2008 Jun; 79 Suppl 1():15-8. PubMed ID: 18927959
[TBL] [Abstract][Full Text] [Related]
10. Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A.
Brashear A; Ambrosius WT; Eckert GJ; Siemers ER
Mov Disord; 1998 Jan; 13(1):158-61. PubMed ID: 9452343
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of spasmotic torticollis with botulinum toxin A. A 5-year experience].
Borgmann R
Tidsskr Nor Laegeforen; 1997 May; 117(13):1889-91. PubMed ID: 9214007
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin type A therapy during pregnancy.
Newman WJ; Davis TL; Padaliya BB; Covington CD; Gill CE; Abramovitch AI; Charles PD
Mov Disord; 2004 Nov; 19(11):1384-5. PubMed ID: 15389988
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type B: an open-label, dose-escalation, safety and preliminary efficacy study in cervical dystonia patients.
Cullis PA; O'Brien CF; Truong DD; Koller M; Villegas TP; Wallace JD
Adv Neurol; 1998; 78():227-30. PubMed ID: 9750919
[No Abstract] [Full Text] [Related]
14. [Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group].
Wissel J; Müller J; Heinen F; Mall V; Sojer M; Ebersbach G; Poewe W
Wien Klin Wochenschr; 1999 Oct; 111(20):837-42. PubMed ID: 10586488
[TBL] [Abstract][Full Text] [Related]
15. Cervical dystonia: a review the role of botulinum toxin.
Edwards LL; Normand MM; Wszolek ZK
Nebr Med J; 1995 May; 80(5):109-15. PubMed ID: 7791942
[TBL] [Abstract][Full Text] [Related]
16. Change in lateralization of the P22/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A.
Kanovský P; Streitová H; Dufek J; Znojil V; Daniel P; Rektor I
Mov Disord; 1998 Jan; 13(1):108-17. PubMed ID: 9452335
[TBL] [Abstract][Full Text] [Related]
17. [A case report of acute polyradiculoneuritis developing after multiple injections of botulinum toxin for cervical dystonia].
Onoue H; Matsunobu A; Nagaishi A; Yukitake M; Kuroda Y
Rinsho Shinkeigaku; 2004 Jan; 44(1):20-4. PubMed ID: 15199733
[TBL] [Abstract][Full Text] [Related]
18. Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay.
Brin MF; Comella CL; Jankovic J; Lai F; Naumann M;
Mov Disord; 2008 Jul; 23(10):1353-60. PubMed ID: 18546321
[TBL] [Abstract][Full Text] [Related]
19. [Botulinum toxin in therapy of craniocervical dystonia].
Dressler D; Benecke R; Conrad B
Nervenarzt; 1989 Jul; 60(7):386-93. PubMed ID: 2668776
[TBL] [Abstract][Full Text] [Related]
20. Fast voluntary neck movements in patients with cervical dystonia: a kinematic study before and after therapy with botulinum toxin type A.
Gregori B; Agostino R; Bologna M; Dinapoli L; Colosimo C; Accornero N; Berardelli A
Clin Neurophysiol; 2008 Feb; 119(2):273-80. PubMed ID: 18063411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
